Invivyd, Inc. — Director's Dealing 2022

Dec 6, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Invivyd, Inc. (IVVD)
CIK: 0001832038
Period of Report: 2022-12-06

Reporting Person: Schmidt Peter (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-06	Stock Option (Right to Buy)	$1.95	A	300000	Acquired	2032-12-05	Common Stock (300000)	Direct

Footnotes

F1: This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date of December 6, 2022, subject to the Reporting Person's continuous service as of each vesting date.